Stay updated on Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Expanded the Locations section with new study sites (Connecticut, District of Columbia, Illinois, Maryland, Massachusetts, Michigan, Missouri, North Carolina, Pennsylvania, Tennessee, Washington, Ontario, Quebec) and removed the previous location groupings.
    Difference
    1%
    Check dated 2025-12-23T20:44:02.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    Publications section now notes that entries are automatically filled from PubMed, and the Revision label was updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T22:01:31.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Removed the government funding status banner that warned of possible delays and directed users to opm.gov; core trial details remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-17T20:07:23.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Visual and structural updates to the page are evident. Core study details, interventions, outcomes, and locations appear unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T14:22:04.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    - Added a government funding notice and open status information for the NIH Clinical Center, and a link to operating status timelines. - Updated software revision to v3.2.0. - Removed the resource topic: Carcinoma of esophagus from Genetic and Rare Diseases Information Center.
    Difference
    3%
    Check dated 2025-10-06T04:28:46.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T01:10:03.000Z thumbnail image

Stay in the know with updates to Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial page.